Immune overdrive signature in colorectal tumor subset predicts poor clinical outcome
Open accessThe DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
The prognostic value of immune cell infiltration within the tumor microenvironment (TME) has been extensively investigated via histological and genomic approaches. Based on the positive prognostic value of T cell infiltration, Immunoscore has been developed and validated for predicting risk of recurrence for colorectal cancer (CRC). Also, association between a consensus T helper 1 (Th-1) immune response and favorable clinical outcomes has been observed across multiple cancer types. Here, we reanalyzed public genomic data sets from The Cancer Genome Atlas (TCGA) and NCBI Gene Expression Omnibus (NCBI-GEO) and performed multispectral immunohistochemistry (IHC) on a cohort of colorectal tumors. We identified and characterized a risk group, representing approximately 10% of CRC patients, with high intratumoral CD8+ T cell infiltration, but poor prognosis. These tumors included both microsatellite instable (MSI) and stable (MSS) phenotypes and had a high density of tumor-associated macrophages (TAMs) that expressed CD274 (programmed death-ligand 1 [PD-L1]), TGF-β activation, and an immune overdrive signature characterized by the overexpression of immune response and checkpoint genes. Our findings illustrate that CRC patients may have poor prognosis despite high CD8+ T cell infiltration and provide CD274 as a simple biomarker for identifying these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Although the majority of CRCs with high CTLs infiltration have favourable outcomes, those with concurrently high PD-L1 gene expression have poor clinical outcomes.44”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robust enumeration of cell subsets from tissue expression profiles
Newman, A. M., Liu, C. L., Green, M. R., Gentles, A. J., Feng, W., Xu, Y., Hoang, C. D., Diehn, M., & Alizadeh, A. A. (2015) · Nature Methods · doi:10.1038/nmeth.3337 · Cited by 13,224
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N. S., Laheru, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500596 · Cited by 9,377
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
Leek, J. T., Johnson, W. E., Parker, H. S., Jaffe, A. E., & Storey, J. D. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts034 · Cited by 6,231
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Mariathasan, S., Turley, S. J., Nickles, D., Castiglioni, A., Yuen, K., Wang, Y., Kadel III, E. E., Koeppen, H., Astarita, J. L., Cubas, R., et al. (2018) · Nature · doi:10.1038/nature25501 · Cited by 5,400
affy—analysis of Affymetrix GeneChip data at the probe level
Gautier, L., Cope, L., Bolstad, B. M., & Irizarry, R. A. (2004) · Bioinformatics · doi:10.1093/bioinformatics/btg405 · Cited by 5,218
The consensus molecular subtypes of colorectal cancer
Guinney, J., Dienstmann, R., Wang, X., de Reyniès, A., Schlicker, A., Soneson, C., Marisa, L., Roepman, P., Nyamundanda, G., Angelino, P., et al. (2015) · Nature Medicine · doi:10.1038/nm.3967 · Cited by 5,170
The immune contexture in human tumours: impact on clinical outcome
Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981
Tumour-associated macrophages as treatment targets in oncology
Mantovani, A., Marchesi, F., Malesci, A., Laghi, L., & Allavena, P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.217 · Cited by 4,033
Research works printed but not linked: 1
- Mandrekar JN, Mandrekar SJ, Cha SS. Cutpoint determination methods in survival analysis using SAS. Paper presented at the 28th SAS Users Group International Conference (SUGI). March 30-April 2, 2003; Seattle, WA. https://support.sas.com/ resources/papers/proceedings/proceedings/ sugi28/261-28.pdf. Accessed August 1, 2019.
Cited by
Wang, L., Tang, L., Feng, Y., Zhao, S., Han, M., Zhang, C., Yuan, G., Zhu, J., Cao, S., Wu, Q., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-320105 · Cited by 630
“44 In the present study, the proportion of PD-1 + CTLs was significantly reduced in CAC mice treated with pasteurised A. muciniphila or Amuc_1100.”
BackgroundLiu, F., Qin, L., Liao, Z., Song, J., Yuan, C., Liu, Y., Wang, Y., Xu, H., Zhang, Q., Pei, Y., et al. (2020) · Experimental Hematology & Oncology · doi:10.1186/s40164-020-00165-3 · Cited by 126
Ferroptosis and the tumor microenvironment
Cui, K., Wang, K., & Huang, Z. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03235-0 · Cited by 132
Chen, J., Sun, H.-W., Yang, Y., Chen, H., Yu, X.-J., Wu, W., Xu, Y.-T., Jin, L.-L., Wu, X., Xu, J., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00377-3 · Cited by 115
TGF-β Mediated Immune Evasion in Cancer—Spotlight on Cancer-Associated Fibroblasts
Ghahremanifard, P., Chanda, A., Bonni, S., & Bose, P. (2020) · Cancers · doi:10.3390/cancers12123650 · Cited by 108
Yang, Z., Gao, J., Zheng, J., Han, J., Li, A., Liu, G., Sun, Y., Zhang, J., Chen, G., Xu, R., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01762-y · Cited by 96
Effect of P2X7 receptor on tumorigenesis and its pharmacological properties
Zhang, W., Hu, C., Zhu, J., & Luo, H. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.109844 · Cited by 60
Functional and Therapeutic Significance of Tumor-Associated Macrophages in Colorectal Cancer
Li, Y., Chen, Z., Han, J., Ma, X., Zheng, X., & Chen, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.781233 · Cited by 64
Zhang, Y., Zhao, Y., Li, Q., & Wang, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.685978 · Cited by 59
The intratumor microbiome is associated with microsatellite instability
Byrd, D. A., Fan, W., Greathouse, K. L., Wu, M. C., Xie, H., & Wang, X. (2023) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djad083 · Cited by 53
Prognostic Impact of PD‐1 and Tim‐3 Expression in Tumor Tissue in Stage I‐III Colorectal Cancer
Kuai, W., Xu, X., Yan, J., Zhao, W., Li, Y., Wang, B., Yuan, N., Li, Z., & Jia, Y. (2020) · BioMed Research International · doi:10.1155/2020/5294043 · Cited by 46
Zhou, J., Li, S., Han, M., Hu, G., & Cheng, P. (2020) · PubMed Central · Cited by 39
Andreuzzi, E., Fejza, A., Polano, M., Poletto, E., Camicia, L., Carobolante, G., Tarticchio, G., Todaro, F., Carlo, E. D., Scarpa, M., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02271-y · Cited by 40
Tanaka, A., Zhou, Y., Ogawa, M., Shia, J., Klimstra, D. S., Wang, J. Y., & Roehrl, M. H. A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229252 · Cited by 37
Integrin β7 Inhibits Colorectal Cancer Pathogenesis via Maintaining Antitumor Immunity
Zhang, Y., Xie, R., Zhang, H., Zheng, Y., Lin, C., Yang, L., Huang, M., Li, M., Song, F., Lu, L., et al. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0879 · Cited by 40
Zhu, X., Fang, H., Gladysz, K., Barbour, J. A., & Wong, J. W. H. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.08.003 · Cited by 35
Zhang, H., Deng, S.-H., Pi, Y., Guo, J., Xi, H., Shi, X., Yang, X.-F., Zhang, B., Xue, W., Cui, B., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.855849 · Cited by 40
Wen, Z., Zhang, Y., Wang, X., Wu, Y., Mao, J., Li, Q., & Gong, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713312 · Cited by 35
Fang, Z., Xu, S., Xie, Y., & Yan, W. (2021) · World Journal of Surgical Oncology · doi:10.1186/s12957-020-02116-y · Cited by 31
Cui, K., Yao, S., Zhang, H., Zhou, M., Liu, B., Cao, Y., Fei, B., Huang, S., & Huang, Z. (2021) · Oncogene · doi:10.1038/s41388-021-01677-w · Cited by 33
Gao, L., Jiang, W., Yue, Q., Ye, R., Li, Y., Hong, J., & Zhang, M. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109335 · Cited by 31
Martínez-Morilla, S., Zugazagoitia, J., Wong, P. F., Kluger, H. M., & Rimm, D. L. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1864909 · Cited by 28
TOX Acts as a Tumor Suppressor by Inhibiting mTOR Signaling in Colorectal Cancer
Yang, M., Huang, Q., Li, C., Jiang, Z., Sun, J. P., Wang, Z., Liang, R., Li, D., Li, B., & Zhao, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.647540 · Cited by 30
Meng, X., Na, R., Peng, X., Li, H., Ouyang, W., Zhou, W., You, X., Li, Y., Pu, X., Zhang, K., et al. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01495-z · Cited by 31
The prognostic value and potential mechanism of Matrix Metalloproteinases among Prostate Cancer
Geng, X., Chen, C., Huang, Y., & Hou, J. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.46780 · Cited by 27
GARP Correlates With Tumor-Infiltrating T-Cells and Predicts the Outcome of Gastric Cancer
Jiang, S., Zhang, Y., Zhang, X., Lu, B., Sun, P., Wu, Q., Ding, X., & Huang, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.660397 · Cited by 30
A novel high-risk subpopulation identified by CTSL and ZBTB7B in gastric cancer
Cui, K., Yao, S., Liu, B., Sun, S., Gong, L., Li, Q., Fei, B., & Huang, Z. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01936-x · Cited by 29
Vitale, C., Bottino, C., & Castriconi, R. (2023) · Cells · doi:10.3390/cells12060885 · Cited by 29
Shen, R., Huang, Y., Kong, D., Ma, W., Liu, J., Zhang, H., Cheng, S., & Feng, L. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05418-x · Cited by 28
Zhang, R., Li, T., Wang, W., Gan, W., Lv, S., Zeng, Z., Hou, Y., Yan, Z., & Yang, M. H. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.594098 · Cited by 24
Wang, X., Yuwen, T.-J., Zhong, Y., Li, Z., & Wang, X.-Y. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e13211 · Cited by 25
Jiang, T., Zheng, J., Li, N., Li, X., He, J., Zhou, J., Sun, B., & Chi, Q. (2024) · Current Gene Therapy · doi:10.2174/0115665232294568240201073417 · Cited by 23
Liu, Y., Liang, Y., Su, Y., Hu, J., Sun, J., Zheng, M., & Huang, Z. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107432 · Cited by 21
Suppressive Myeloid Cells Shape the Tumor Immune Microenvironment
Xiong, J., Wang, H., & Wang, Q. (2021) · Advanced Biology · doi:10.1002/adbi.201900311 · Cited by 21
Ye, J., Guo, W., Wang, C., Egelston, C. A., D’Apuzzo, M., Shankar, G., Fakih, M., & Lee, P. P. (2023) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0212 · Cited by 22
Millen, R., Hendry, S. A., Narasimhan, V., Abbott, R. C., Croxford, M. A., Gibbs, P., Tie, J., Wong, H., Jones, I. T., Kosmider, S., et al. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1155 · Cited by 21
Association of the Psoriatic Microenvironment With Treatment Response
Wang, G., Miao, Y., Kim, N., Sweren, E., Kang, S., Hu, Z., & Garza, L. A. (2020) · JAMA Dermatology · doi:10.1001/jamadermatol.2020.2118 · Cited by 18
Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment trials
Ledenko, M., Antwi, S. O., Arima, S., Driscoll, J., Furuse, J., Klümpen, H., Larsen, F. O., Lau, D. K., Maderer, A., Markussen, A., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.963753 · Cited by 16
Zhao, S., Pan, W., Jiang, H., Zhang, R., Liang, Z., Liang, Z., & Hu, H. (2020) · EJNMMI Research · doi:10.1186/s13550-020-00654-w · Cited by 14
Che, Y., Luo, Z., Zhang, C., Sun, N., Gao, S., & He, J. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106802 · Cited by 12
Current and Prospective Methods for Assessing Anti-Tumor Immunity in Colorectal Cancer
Nussbaum, Y. I., Manjunath, Y., Suvilesh, K. N., Warren, W. C., Shyu, C., Kaifi, J. T., Ciorba, M. A., & Mitchem, J. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094802 · Cited by 12
Jiang, S., Ding, X., Wu, Q., Cheng, T., Xu, M., & Huang, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.980986 · Cited by 10
Wang, Z., Lu, H., Wu, Y., Ren, S., Diaty, D. M., Fu, Y., Zou, Y., Zhang, L., Wang, Z., Wang, F., et al. (2023) · CAAI Transactions on Intelligence Technology · doi:10.1049/cit2.12175 · Cited by 10
Huang, F., Wang, Y., Shao, Y., Zhang, R., Li, M., Liu, L., & Zhao, Q. (2024) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s458798 · Cited by 16
Koemans, W. J., van Dieren, J. M., van den Berg, J. G., Meijer, G. A., Snæbjörnsson, P., Chalabi, M., LECOT, F., Riedl, R. G., Krijgsman, O., Hofland, I., et al. (2021) · Histopathology · doi:10.1111/his.14361 · Cited by 12
Tong, M., Lin, Y., Yang, W., Song, J., Zhang, Z., Xie, J., Tian, J., Luo, S., Liang, C., Huang, J., et al. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad078 · Cited by 12
Kinase Inhibitors’ Effects on Innate Immunity in Solid Cancers
Peng, C., Rabold, K., Mulder, W. J. M., Jaeger, M., & Netea-Maier, R. T. (2021) · Cancers · doi:10.3390/cancers13225695 · Cited by 7
Lu, Y., Zhou, X., Liu, Z., Wang, B., Wang, W., & Fu, W. (2020) · DNA and Cell Biology · doi:10.1089/dna.2019.5195 · Cited by 7
Miao, Y., Gan, J., Ni, Y.-J., Zhang, Z., Yu, L.-X., Quan, W., Zhang, Z., Wang, H., Han, S., Qu, F.-Y., et al. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000002506 · Cited by 9
Targeting ribosomes reprograms the tumour microenvironment and augments cancer immunotherapy
Cui, K., Liu, B., Gong, L., Wan, Q., Tang, H., Gong, Z., Shen, R., Wang, C., Zhang, Q., Li, Q., et al. (2025) · British Journal of Cancer · doi:10.1038/s41416-025-03109-y · Cited by 8
Wang, G., Yu, Y., Li, Z., Zhu, Z., Wang, Z.-J., & Tao, M.-F. (2021) · Nutrition and Cancer · doi:10.1080/01635581.2021.2009523 · Cited by 6
Cui, K., Gong, L., Wang, K., Wang, Y., Huang, L., Liu, B., Li, Q., Zhang, Q., Fei, B., & Huang, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.888757 · Cited by 5
Ye, R., Zeng, H., Liu, Z., Jin, K., Liu, C., Yan, S. R., Yu, Y., You, R., Zhang, H., Chang, Y., et al. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-02987-4 · Cited by 5
Prognostic risk of immune-associated signature in the microenvironment of brain gliomas
Tao, Y., Zhu, J., Yu, X., Cong, H., Li, J., Cai, T., & Chen, Q. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1208651 · Cited by 5
An artificial intelligence-based ecological index for prognostic evaluation of colorectal cancer
Chen, Q., Cai, M., Fan, X., Liu, W., Fang, G., Yao, S., Xu, Y., Li, Q., Zhao, Y., Zhao, K., et al. (2023) · BMC Cancer · doi:10.1186/s12885-023-11289-0 · Cited by 6
Zhu, W., Wu, C., Hu, S., Liu, S., Zhao, S., Zhang, D., Qiu, G., Cheng, X., & Huang, J. (2023) · Scientific Reports · doi:10.1038/s41598-023-48623-2 · Cited by 4
Zhang, Y., Cui, K., Yang, Y., Liu, B., Zhu, M., Chen, H., Zhao, C., Zhou, Y., & Nie, Y. (2023) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s410756 · Cited by 3
Wagner, P. L., Xie, J., Flaherty, D. C., Park, H., Knotts, C. M., Debelius, J. W., Tilves, C., Dadgar, N., Xiao, K., Zaidi, A. H., et al. (2024) · Frontiers in Gastroenterology · doi:10.3389/fgstr.2024.1493949 · Cited by 3
Li, Q., Meng, X., 陈卫民, Chen, X., & Mao, J. (2022) · Vaccines · doi:10.3390/vaccines10091521 · Cited by 5
A Robust Prognostic Signature of Tumor Microenvironment in Colorectal Cancer
Liu, J., Yu, F., Liu, Z., Wang, X., & Li, J. (2021) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2021.0171 · Cited by 2
Membrane IL-18 identifies a human macrophage subset with distinct proteomic and functional traits
Vitale, C., Petretto, A., Cortese, K., Carta, S., Dondero, A., Lavarello, C., Cangelosi, D., Morini, M., Bellora, F., Arnaldi, P., et al. (2025) · OncoImmunology · doi:10.1080/2162402x.2025.2571774 · Cited by 2
Zhang, Y., Li, L., Chu, F., Zhang, L., Zhang, L., Wu, H., & Li, K. (2022) · Aging · doi:10.18632/aging.204463 · Cited by 3
Huang, G., Zhang, H., Qu, Y., Huang, K., Gong, X., Wei, J., & Du, H. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.08.009 · Cited by 2
Zhu, L., Qiu, X., Liang, S., Huang, S., Ning, Q., Chen, X., Chen, N., Qin, L., Huang, J., & Liu, S. (2025) · Discover Oncology · doi:10.1007/s12672-025-01964-y · Cited by 1
Da, Y., Chen, X., Yu, L., Li, Y., Chen, Z., Zhang, Y., Wang, H., Zhu, Z., Liu, Y., & Geng, Y. (2025) · Discover Oncology · doi:10.1007/s12672-025-04080-z · Cited by 1
Wang, S., Xu, L., Zhu, K., Zhu, H., Zhang, D., Wang, C., & Wang, Q. (2022) · BMC Medical Genomics · doi:10.1186/s12920-022-01409-3 · Cited by 1
Qiu, Y., Qi, X., Liu, Z., Xu, J., Wang, X., Huang, J., & Jiang, X. (2021) · Research Square · doi:10.21203/rs.3.rs-219462/v1
Tumor infiltrated macrophage-the fighter defends against recurrence of stage Ⅱcolorectal cancerPreprint
Yang, W., Wang, X., Zhang, G.-L., Yu, M., Cao, K., Tan, S.-Y., & Yang, G. (2020) · Research Square · doi:10.21203/rs.3.rs-54018/v1
Li, Q., Meng, X., Chen, W.-M., Chen, X., & Mao, J. (2021) · Research Square · doi:10.21203/rs.3.rs-835864/v1
Identification of key genes controlling docetaxel resistance in patients with breast cancerPreprint
Jiang, Y., Qian, Y., & Qian, W. (2020) · doi:10.21203/rs.3.rs-18265/v1
Gao, L., Jiang, W., Yue, Q., Ye, R., Li, Y., Hong, J., & Zhang, M. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4105044
Tu, H., Zhang, Q., & Xue, L. (2022) · Research Square · doi:10.21203/rs.3.rs-1995727/v1
Zou, Q., Wang, S., Chen, Y., Du, Q., Zhang, C., Liu, J., & Yao, S. (2022) · Research Square · doi:10.21203/rs.3.rs-2320013/v1
Zheng, J. H., Yao, H., Ying, H., Hong, W., & Huang, L. (2024) · Research Square · doi:10.21203/rs.3.rs-4490652/v1
β2-integrins as biomarkers in urothelial cancer
Asens, M. L., Khan, I., & Fagerholm, S. C. (2025) · PLoS ONE · doi:10.1371/journal.pone.0326015
Identification of PLXNC1 as a novel biomarker for consensus molecular subtype 4 in colorectal cancer
Wang, W., Zhou, M., Li, T., Gan, W., Lv, S., Yan, Z., Hou, Y., Zeng, Z., Yang, L., Zhang, F., et al. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101974
Shen, R., Huang, Y., Kong, D., Ma, W., Liu, J., Zhang, H., Cheng, S., & Feng, L. (2024) · Figshare · doi:10.6084/m9.figshare.26741144
Shen, R., Huang, Y., Kong, D., Ma, W., Liu, J., Zhang, H., Cheng, S., & Feng, L. (2024) · Figshare · doi:10.6084/m9.figshare.26741159
Meng, X., Na, R., Peng, X., Li, H., Ouyang, W., Zhou, W., You, X., Li, Y., Pu, X., Zhang, K., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26679977
Shen, R., Huang, Y., Kong, D., Ma, W., Liu, J., Zhang, H., Cheng, S., & Feng, L. (2024) · Figshare · doi:10.6084/m9.figshare.26741153
Shen, R., Huang, Y., Kong, D., Ma, W., Liu, J., Zhang, H., Cheng, S., & Feng, L. (2024) · Figshare · doi:10.6084/m9.figshare.26741147
Meng, X., Na, R., Peng, X., Li, H., Ouyang, W., Zhou, W., You, X., Li, Y., Pu, X., Zhang, K., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25210502
Meng, X., Na, R., Peng, X., Li, H., Ouyang, W., Zhou, W., You, X., Li, Y., Pu, X., Zhang, K., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26679974
Shen, R., Huang, Y., Kong, D., Ma, W., Liu, J., Zhang, H., Cheng, S., & Feng, L. (2024) · Figshare · doi:10.6084/m9.figshare.26741141
Meng, X., Na, R., Peng, X., Li, H., Ouyang, W., Zhou, W., You, X., Li, Y., Pu, X., Zhang, K., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25210846
Shen, R., Huang, Y., Kong, D., Ma, W., Liu, J., Zhang, H., Cheng, S., & Feng, L. (2024) · Figshare · doi:10.6084/m9.figshare.26741156
Shen, R., Huang, Y., Kong, D., Ma, W., Liu, J., Zhang, H., Cheng, S., & Feng, L. (2024) · Figshare · doi:10.6084/m9.figshare.26741150
Ying, H., Huang, L., & Hong, W. (2026) · European Journal of Radiology Open · doi:10.1016/j.ejro.2026.100725
He, L., Song, K., Qiao, S., Chen, Y., Li, J., Lin, Q., & Wang, X. (2025) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm66473.2025.11356123
Metadata
- Authors
- Fakih, M., Ouyang, C., Wang, C., Tu, T. Y., Gozo, M. C., Cho, M., Sy, M., Longmate, J. A., & Lee, P. P.
- Affiliations
- City Of Hope National Medical Center (US)
- Corresponding author
- Fakih, Marwan
- Lee, Peter P.
- Venue
- Journal of Clinical Investigation
- Published
- 2019-09-16
- Volume
- 129
- Issue
- 10
- Pages
- 4464-4476
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC6763253
- OpenAlex
- W2972895479
- Cited by
- 84
- References
- 65
- Citations by year
- 2026: 1 · 2025: 8 · 2024: 14 · 2023: 12 · 2022: 14 · 2021: 18 · 2020: 17
- FWCI
- 5.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- public-domain
- Locations
- Journal of Clinical Investigation (publishedVersion, public-domain)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Comprehensive Cancer Center, City of Hope (Fakih, Lee Start up funds)
- National Cancer Institute (P30CA33572)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- colorectal cancer, CD8+ T cell infiltration, tumor microenvironment, PD-L1, tumor-associated macrophages, TGF-beta activation, microsatellite instability, prognostic factors, immune checkpoint genes, immune response genes, T cell exhaustion
- MeSH terms
- Humans, Immunohistochemistry, Macrophages, Melanoma, Phenotype, Prognosis, Risk Factors, Biomarkers, Tumor, Colorectal Neoplasms, Cohort Studies, Gene Expression, Lymphocytes, Tumor-Infiltrating, CD8 Antigens, CD8-Positive T-Lymphocytes, Databases, Genetic, Microsatellite Instability, B7-H1 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.